Find out how genome sequencing has emerged and what the future holds for one of biotech's most important tools.

Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

Researchers developed a machine learning model, PAMmla, to predict properties of CRISPR-Cas9 enzymes, enhancing precision and ...

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions -- but there is always room for improvement. A new paper showcases the power of scalable protein ...

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions—but there is always room ...

Researchers have developed a machine learning model that predicts Cas9 proteins that can be tailored with designer properties for therapeutic use.

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions—but there is always room for improvement. A new ...

ToolGen, Inc. (KOSDAQ 199800), led by CEO Jong Sang Ryu and recognized as a global leader in genome editing technology, announced today that it has filed a patent infringement lawsuit in the United ...

To better understand what NGTs are and how they work, Euronews Tech Talks went to Hertfordshire, a county just north of ...

A new set of genes that contribute to Parkinson’s disease risk has been identified.

For the first time, Professor Veyrier and his team at INRS have discovered a family of enzymes that can cut specific ...